The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J01 | Antibacterials for systemic use | |
3
|
J01E | Sulfonamides and trimethoprim | |
4
|
J01EA | Trimethoprim and derivatives |
| Code | Title | |
|---|---|---|
| J01EA01 | Trimethoprim | |
| J01EA02 | Brodimoprim |
| Active Ingredient |
|---|
|
Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells. |
| Document | Type | Information Source | |
|---|---|---|---|
| TRIMOPTIN Tablet | MPI, EU: SmPC | Health Products Regulatory Authority (IE) |